MannKind, Sagard Healthcare in Royalty Purchase Agreement for Up to $200 M

 

• Sagard Healthcare purchased a 1% royalty in Tyvaso DPI® net sales
  
• Purchase price of $150 million; additional potential milestone payment of up to $50 million

https://www.globenewswire.com/news-release/2024/01/02/2802534/29517/en/MannKind-and-Sagard-Healthcare-Enter-Into-Royalty-Purchase-Agreement-for-Up-to-200-Million.html